temozolomide has been researched along with Synovioma in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Synovial sarcoma is a soft-tissue sarcoma and a rare type of cancer." | 1.43 | Synovial sarcoma cell lines showed reduced DNA repair activity and sensitivity to a PARP inhibitor. ( Kondo, T; Miyamoto, M; Ohta, T; Watanabe, T; Yamamoto, Y; Yamasaki, H, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bazan, F | 1 |
| Vollmer, I | 1 |
| Gayete, A | 1 |
| Yamasaki, H | 1 |
| Miyamoto, M | 1 |
| Yamamoto, Y | 1 |
| Kondo, T | 1 |
| Watanabe, T | 1 |
| Ohta, T | 1 |
2 other studies available for temozolomide and Synovioma
| Article | Year |
|---|---|
Chemotherapy-induced secondary pneumothorax.
Topics: Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizuma | 2014 |
Synovial sarcoma cell lines showed reduced DNA repair activity and sensitivity to a PARP inhibitor.
Topics: Cell Line, Tumor; Cell Proliferation; Dacarbazine; DNA Damage; DNA Repair; Etoposide; Humans; Phthal | 2016 |